2009-NP-Actavis-Clamelle

Print

The New Product of the Year Award (Europe) 2009

Date: 29/04/2009

Actavis’ OTC product Clamelle has been awarded the prestigious Nicholas Hall European New Product of the Year Award. Awarded for the most innovative and successful new product launch or ‘Pom to P’ (prescription to OTC/without prescription) switch, Clamelle from Actavis was a clear winner as the first OTC oral antibiotic (azithromycin 500mg), as well as being supplied as part of a professional service and a diagnostic test.

Accepting the award, Richard Hollies, Actavis’ OTC Marketing Director, paid tribute to the hard work and dedication of the Actavis UK team in steering through this unique switch. Since their creation, the Nicholas Hall Marketing & Creative Awards have highlighted and rewarded outstanding achievements in European OTC marketing, and have done much to spur ever higher standards of innovation and execution in the industry.

This award builds on Clamelle’s success earlier in the year when the Clamelle Chlamydia Service was awarded ‘Best POM to P switch of the Year’ at the SMaRT Awards and ‘Most Innovative New OTC Product’ at the OTC Marketing Awards.

Press Release from Actavis - 05 May 2009